Skip to main content

Lizak Carol R.'s Form 4 filing

Jaguar Health, Inc. (JAGX) · filed Mar 30, 2022

Accession no.
0001104659-22-040397
Filed
Mar 30, 2022
Trade date
Sep 13, 2021-Mar 28, 2022
Filing delay
198 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $20.0K. It was filed 198 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lizak Carol R.CIK 0001785794Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 13, 2021Common StockPPurchaseAcquired+7,968$2.51+$19,999.687,968Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 28, 2022Common StockAGrant or awardAcquired+97,025$0.00$097,025Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)